CD274 and neoplasm: (48) encapsulated the cyclin-dependent kinase inhibitor dinaciclib into lipid nanoparticles containing anti-PD-L1 antibodies, and RT induced the up-regulation of PD-L1 in glioma infiltrating TAMC (Tumor-associated myeloid cells).